Cargando…

Targeted metabolomics in colorectal cancer: a strategic approach using standardized laboratory tests of the blood and urine

BACKGROUND: Glycolytic markers have been detected in colorectal cancer (CRC) using advanced analytical methods. METHODS: Using commercially available assays, by-products of anaerobic metabolism were prospectively measured in the blood and urine of 20 patients with metastatic colorectal cancer (mCRC)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jerzak, Katarzyna J, Laureano, Marissa, Elsharawi, Radwa, Kavsak, Peter, Chan, Kelvin KW, Dhesy-Thind, Sukhbinder K, Zbuk, Kevin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5449104/ https://www.ncbi.nlm.nih.gov/pubmed/28580363 http://dx.doi.org/10.2147/HP.S127560

Ejemplares similares

Detection of Macrotroponin in Patients Receiving Treatment for Breast Cancer
por: Kavsak, Peter A., et al.
Publicado: (2023)

Generalizability of toxicity data from oncology clinical trials to clinical practice: toxicity of irinotecan-based regimens in patients with metastatic colorectal cancer
por: Tam, V.C., et al.
Publicado: (2009)

Statin therapy in the treatment of active cancer: A systematic review and meta-analysis of randomized controlled trials
por: Farooqi, Mohammed A. M., et al.
Publicado: (2018)

Breaking silence: a survey of barriers to goals of care discussions from the perspective of oncology practitioners
por: Piggott, Katrina Lynn, et al.
Publicado: (2019)

Feasibility outcomes of a randomised, multicentre, pilot trial comparing standard 6-monthly dosing of adjuvant zoledronate with a single one-time dose in patients with early stage breast cancer
por: Awan, Arif, et al.
Publicado: (2020)

Three-Year Outcomes Following Permissive Cardiotoxicity in Patients on Trastuzumab
por: Zhou, Shijie, et al.
Publicado: (2023)

Predictors of medical student interest and confidence in research during medical school
por: Klowak, Jennifer, et al.
Publicado: (2018)

Pertuzumab Cardiotoxicity in Patients With HER2-Positive Cancer: A Systematic Review and Meta-analysis
por: Alhussein, Muhammad Mustafa, et al.
Publicado: (2021)

Urine NMR Metabolomics for Precision Oncology in Colorectal Cancer
por: Brezmes, Jesús, et al.
Publicado: (2022)

Urine-NMR metabolomics for screening of advanced colorectal adenoma and early stage colorectal cancer
por: Kim, Eun Ran, et al.
Publicado: (2019)

The Human Urine Metabolome
por: Bouatra, Souhaila, et al.
Publicado: (2013)

Ex vivo expanded natural killer cells from breast cancer patients and healthy donors are highly cytotoxic against breast cancer cell lines and patient-derived tumours
por: Shenouda, Mira M., et al.
Publicado: (2017)

Development of a strategic approach for comprehensive detection of organophosphate pesticide metabolites in urine: Extrapolation of cadusafos and prothiofos metabolomics data of mice to humans
por: Nomasa, Karin, et al.
Publicado: (2021)

Recommendations and Best Practices for Standardizing the Pre-Analytical Processing of Blood and Urine Samples in Metabolomics
por: González-Domínguez, Raúl, et al.
Publicado: (2020)

Emerging key laboratory tests for patients with COVID-19
por: Kavsak, Peter A., et al.
Publicado: (2020)

Medical students’ challenges and suggestions regarding research training: a synthesis of comments from a cross- sectional survey
por: Riva, John J., et al.
Publicado: (2019)

Urine Metabolome during Parturition
por: Gevi, Federica, et al.
Publicado: (2020)

Urine metabolomics as a predictor of patient tolerance and response to adjuvant chemotherapy in colorectal cancer
por: Dykstra, Mark A., et al.
Publicado: (2017)

Data from an incentivized laboratory experiment on strategic medical choices
por: Ge, Ge, et al.
Publicado: (2021)

Improving Medical Education in Hematology and Transfusion Medicine in Canada: Standards and Limitations
por: Laureano, Marissa, et al.
Publicado: (2021)

Comprehensive Volatilome and Metabolome Signatures of Colorectal Cancer in Urine: A Systematic Review and Meta-Analysis
por: Mallafré-Muro, Celia, et al.
Publicado: (2021)

Safety of Continuing Trastuzumab Despite Mild Cardiotoxicity: A Phase I Trial
por: Leong, Darryl P., et al.
Publicado: (2019)

Expanded human NK cells armed with CAR uncouple potent anti-tumor activity from off-tumor toxicity against solid tumors
por: Portillo, Ana L., et al.
Publicado: (2021)

Metabolomic Biomarkers in Serum and Urine in Women with Preeclampsia
por: Austdal, Marie, et al.
Publicado: (2014)

Urine metabolomics in rats after administration of ketamine
por: Wen, Congcong, et al.
Publicado: (2015)

Urine metabolome in women with Chlamydia trachomatis infection
por: Foschi, Claudio, et al.
Publicado: (2018)

Metabolomic Biomarkers in Urine of Cushing’s Syndrome Patients
por: Kotłowska, Alicja, et al.
Publicado: (2017)

Urine metabolomics of rats with chronic atrophic gastritis
por: Zu, Guo-Xiu, et al.
Publicado: (2020)

CKD Urine Metabolomics: Modern Concepts and Approaches
por: Danilova, Elena Y., et al.
Publicado: (2023)

Strategic Insight into the Combination Therapies for Metastatic Colorectal Cancer
por: Kano, Yoshihito, et al.
Publicado: (2023)

Laboratory Evidence of the Presence of Demodex in Urine Laboratory: A Case Report
por: Hatami, Arman, et al.
Publicado: (2021)

Data on hydroxychloroquine interference with urine laboratory testing
por: Kingery, Jennie M., et al.
Publicado: (2019)

Translating a National Laboratory Strategic Plan into action through SLMTA in a district hospital laboratory in Botswana
por: Ntshambiwa, Keoratile, et al.
Publicado: (2014)

Pharmacotherapy in the cardiac catheterization laboratory: evolution and recent developments
por: Thind, Guramrinder S, et al.
Publicado: (2014)

Strategic establishment of an International Pharmacology Specialty Laboratory in a resource-limited setting
por: Mtisi, Takudzwa J., et al.
Publicado: (2018)

A balanced scorecard for assessing a strategic plan in a clinical laboratory
por: Alvarez, Luisa, et al.
Publicado: (2019)

Urine metabolome profiling of immune-mediated inflammatory diseases
por: Alonso, Arnald, et al.
Publicado: (2016)

Bladder cancer recurrence surveillance by urine metabolomics analysis
por: Loras, A., et al.
Publicado: (2018)

Real-time health monitoring through urine metabolomics
por: Miller, Ian J., et al.
Publicado: (2019)

A molecular signature for the metabolic syndrome by urine metabolomics
por: Bruzzone, Chiara, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_17oec82f12a39o7umh2igopnrd